Treatment of Gastroesophageal Reflux Disease in Infants

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Gastroesophageal Reflux, Infant, Newborn, Diseases

In brief

Gastroesophageal reflux disease in infants is not fully understood. Infants are prescribed medical treatments that may not be effective or that contribute to adverse side effects and lead to concerns and expenses for the parents and healthcare system. Current guidelines recommend cow-milk-protein free diet as a first-line treatment, but these recommendations are based on weak evidence. This study investigate the efficacy of a cow-milk-protein free diet compared to treatment with a proton pump inhibitor (omeprazole)

Key facts

Study ID
NCT06255886
Run by
Odense University Hospital
People needed
96
Starts
2025-10-27
Expected to finish
2026-12-26
Last updated by the study team
2025-11-20

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.